MedPage TodayDr. Scher on Corticosteroids and Enzalutamide in mCRPCOncLiveHoward I. Scher, MD, Chief of the Genitourinary Oncology Service at the Sidney Kimmel Center for Prostate and Urologic Cancers at Memorial Sloan-Kettering Cancer Center, discusse…

FDA Nod For Novartis Drug To Avert Organ Failure In Liver TransplantNASDAQThe approval also means that Zortress (everolimus) is the first mammalian target of rapamycin (mTOR) inhibitor to prevent organ rejection in adult liver transplant patients in th…

US FDA okays Novartis drug to prevent liver transplant rejectionReutersThe immune system drug, also known as everolimus, is already approved by the Food and Drug Administration for preventing organ rejection for kidney transplant patients. Regulators i…

OncLiveConcomitant Corticosteroid Use Compromises Efficacy of Enzalutamide in mCPRCOncLiveUse of corticosteroids had a negative impact on outcomes with enzalutamide treatment as well as placebo treatment in men with metastatic castrate resistant prosta…

Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R …7thSpace Interactive (press release)IntroductionThis study investigated whether the calcineurin inhibitor, tacrolimus, suppresses receptor activator of NF-kappaB ligand (RANKL) e…